Chris Cargill

Amministratore Delegato presso NXERA PHARMA CO., LTD.

42 anni

Health Technology

Consumer Services

Profilo

Chris Cargill is currently the President, CEO & Representative Director at Nxera Pharma Co., Ltd. since 2022.
He is also currently a Director at Nxera Pharma UK Ltd. since 2019.
Previously, he worked as a Director at Sosei R&D Ltd. Mr. Cargill completed his undergraduate degree at Monash University.

Posizioni attive di Chris Cargill

Società	Posizione	Inizio
NXERA PHARMA CO., LTD.	Amministratore Delegato	24/03/2022
Nxera Pharma UK Ltd. Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors	Direttore/Membro del Consiglio	01/01/2019

Tutte le posizioni attive di Chris Cargill

Precedenti posizioni note di Chris Cargill

Società	Posizione	Fine
Sosei R&D Ltd. Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Chris Cargill

Formazione di Chris Cargill

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Chris Cargill

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Monash University Monash University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sosei R&D Ltd. Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Nxera Pharma Co., Ltd. Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products	Health Technology
Nxera Pharma UK Ltd. Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors	Health Technology